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Abstract: The material for bone scaffold replacement should be biocompatible and antibacterial
to prevent scaffold-associated infection. We biofunctionalized the hydroxyapatite (HA) properties
by doping it with lithium (Li). The HA and 4 Li-doped HA (0.5, 1.0, 2.0, 4.0 wt.%) samples were
investigated to find the most suitable Li content for both aspects. The synthesized nanoparticles, by
the mechanical alloying method, were cold-pressed uniaxially and then sintered for 2 h at 1250 ◦C.
Characterization using field-emission scanning electron microscopy (FE-SEM) revealed particle
sizes in the range of 60 to 120 nm. The XRD analysis proved the formation of HA and Li-doped HA
nanoparticles with crystal sizes ranging from 59 to 89 nm. The bioactivity of samples was investigated
in simulated body fluid (SBF), and the growth of apatite formed on surfaces was evaluated using SEM
and EDS. Cellular behavior was estimated by MG63 osteoblast-like cells. The results of apatite growth
and cell analysis showed that 1.0 wt.% Li doping was optimal to maximize the bioactivity of HA.
Antibacterial characteristics against Escherichia coli (E. coli) and Staphylococcus aureus (S. aureus)
were performed by colony-forming unit (CFU) tests. The results showed that Li in the structure of HA
increases its antibacterial properties. HA biofunctionalized by Li doping can be considered a suitable
option for the fabrication of bone scaffolds due to its antibacterial and unique bioactivity properties.
Keywords: hydroxyapatite; Li doping; mechanical alloying; bioactivity; antibacterial
1. Introduction
Bioceramic scaffolds have been broadly employed for the treatment of hard tissues
such as bones, joints, and teeth, owing to their outstanding chemical stability and non-
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toxicity [1,2]. Among the various bioceramics, hydroxyapatite (HA) with the chemical
composition of Ca10(PO4)6(OH)2 has attracted a great deal of attention. HA has been recog-
nized as the most stable phase of calcium phosphate under physiological conditions and
one of the essential components of hard tissues, including bone and tooth [3,4]. HA charac-
teristics can be enhanced by regulating the size, shape, distribution, and agglomeration of
its particles [5,6]. HA nanoparticles are more desirable for biomedical applications because
of their larger surface area; they also show superior bioactivity and osteoconductivity [7,8].
Since natural bone possesses a nanocrystalline structure, the preparation of HA at the
nanoscale manifests its significant importance. Furthermore, densification and sintering
take place better at the nanoscale [9]. Doping with Mg, Sr, and Si effectively improves the
mechanical, biological and antibacterial behaviors of the HA nanoparticles [10–12]. Due
to charge type and ionic radius, HA can accommodate dopants in its structure, leading to
changes in biological and antibacterial properties. Interestingly, metal dopants, as bioactive
materials, can speed up the formation and proliferation of bone cells [13,14]. Moreover, the
bioactive materials enable the formation of layers such as bone apatite on the HA surface
resulting in strong interfacial bonding [15,16]. Metal dopants such as Li, Zn, Mn, Si, Mg,
and Sr cause enhancement of osteogenesis, the proliferation of osteoblast, and neovascu-
larization. The addition of these dopants to the calcium phosphate structure improves
bone healing [17,18]. The Li element is a great candidate for modifying mechanical as
well as biological behaviors of HA. Besides, there is a trace amount of Li+, as alkali and
bioelectric material, in the human body [19,20]. The results obtained in a study conducted
by Mayer et al. showed that a low amount of Li does not change the crystal structure of
HA [7,21,22] but influences osteoblast cell growth, proliferation, and differentiation via
stimulation of the Wnt signaling pathway that causes bone regeneration [18]. Scaffold-
associated infection results from bacteria that initially colonize the surface of a scaffold
then proceed to form a biofilm. Since bacteria growing in biofilms are tolerant to antibi-
otics and immune cell clearance, the infections are usually only treated by removing the
scaffold in a sophisticated two-step revision surgery which imposes a huge socioeconomic
burden [21,22]. Staphylococcus aureus (S. aureus), the most common bacterium causing
implant-related infection, is resistant to the antibacterial action of methicillin and other
related drugs of the penicillin class, and has been recognized as a concern to human health
for more than a century [23]. Interestingly, inorganic antibacterial agents (metals and metal
oxides) exhibit reduced toxicity, superior chemical stability, and better durability compared
to organic ones [24,25]. For instance, Li has potent immune-stimulating capabilities and is
highly effective against a wide spectrum of bacteria. More importantly, various studies
have shown that Li+ can increase the effect of HA on osteoblast proliferation [26].
In this study, HA nanoparticles with different wt.% Li (0.0, 0.5, 1.0, 2.0, 4.0) were
synthesized by ball-milling, the five samples being named HA, HA-0.5Li, HA-1Li, HA-2Li,
and HA-4Li. The effects of Li on particle size, morphology, bioactivity, cell proliferation,
and antibacterial property were studied. Ball-milling was used for nanoscale powder
synthesis because of its simplicity and its economical and characteristic aspects. The
doping of Li in HA derived from natural resources instead of synthetic HA, as well as
the ball-milling technique, are both novel aspects of this work. As HA generated from
natural sources can form a strong chemical link with the body’s living bone tissue, the HA




The XRD patterns for samples are shown in Figure 1. All the XRD patterns showed the
same diffraction planes of HA (Ca5(PO4)3OH) with a hexagonal crystal system (JCPDS #
09-0432) and lattice parameters of a = b = 0.9418 nm and c = 0.6884 nm. No new peaks were
observed in the HA-0.5Li and HA-1Li samples. However, the two samples HA-2Li and
HA-4Li exhibited new peaks belonging to the Li-calcium-phosphate phase (Ca10Li(PO4)7,
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JCPDS # 045-0550) [5,19]. The lattice volume (V) and lattice parameters of the samples are
listed in Table 1. Important to note is that adding small amounts of Li dopant changed
the lattice parameters of the HA structure. The ionic radius of any dopant smaller than
Ca2+ (1.14 Å), such as Li+ (0.90 Å), leads to the reduction of lattice volume [20,31]. The
measured parameters for the HA sample in this study are in accord with those available in
the literature [5]; nonetheless, they decreased for the Li-doped samples. The estimated data
of the crystallinity percentage (%Xc) of samples are also reported in Table 1. Intense and
sharp peaks in the XRD patterns of HA and Li-doped samples corroborated the crystallinity
of structures [9]. The presence of Li+ also affected the crystallization process of HA. Li-
doped samples had a higher crystallinity percentage compared to the HA. Based on the
obtained data, the crystallinity increased from 95% to 98% upon adding Li up to 1.0 wt.%
but decreased from 98% to 96% for the 4.0 wt.% Li content. The relative density of samples
is shown in Table 2. According to this table, the density of HA-0.5Li and HA-1Li samples
increased. The density and the Li+ radius being smaller than those of Ca+, and thus, when
up to 1.0 wt.% Li was introduced in the HA structure, the density increased. However, the
density decrease with higher Li in the HA structure was attributed to the formation of the
Li-calcium-phosphate phase [5,19].




Figure 1. XRD pattern of: (a) HA. (b) HA-0.5Li. (c) HA-1Li. (d) HA-2Li. (e) HA-4Li sintered 
at 1250 °C. 
Figure 2 shows that all five samples had a similar FTIR spectrum. The absorption 
bands at 440, 573, 602, 961, and 1000–1100 cm−1 were assigned to the vibrational modes of 
tetrahedral phosphate ions (PO43−) in HA. The absorption bands characteristic of the lib-
eration and stretching vibration of the hydroxyl group in HA were located at 631, 3567, 
3642 cm−1. The LiO2Li bond was seen at 810 cm−1. The absorption band split into two bands 
at 1462 and 1411 cm−1 corresponded to the carbonate (CO32−) species originating from at-
mospheric CO2. The mentioned bonds are the main characteristics for the formation of 
type-B carbonated apatite, in which CO32- substitutes PO43−. The bands at 1646, 2980, and 
3431 cm−1 were for the adsorbed water molecules [8,19,32,33]. 
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The FE-SEM micrographs in Figure 3 show the surface morphology of the synthe-
sized powders by ball-milling before sintering at 1250 °C. It can be observed that the Li 
dopant had no considerable effect on the morphology and size of the HA nanoparticles. 
There are spherical agglomerates on the surface of larger particles possessing various size 
distributions. Figure 4 shows the FE-SEM micrographs of the fracture surfaces of samples 
after sintering. The Li-doped samples had heterogeneous microstructures, except for HA-
Figure 1. XRD pattern of: (a) HA. (b) HA-0.5Li. (c) HA-1Li. (d) HA-2Li. (e) HA-4Li sintered at
1250 ◦C.
Table 1. Diffraction characteristics of HA and Li-dope HA samples.
Sample Lattice Parameters (nm) Unit Cell Volume (nm) Crystallinity (%)
HA a = b = 0.9422; c = 0.6886 0.5298 95
HA-0.5Li a = b = 0.9415; c = 0.6882 0.5287 97
HA-1Li a = b = 0.9411; c = 0.6880 0.5281 98
HA-2Li a = b = 0.9417; c = 0.6883 0.5290 96
HA-4Li a = b = 0.9420; c = 0.6887 0.5297 96
Figure 2 shows t at all fiv samples had a similar FTIR spectrum. The absorption
bands at 440, 573, 602, 961, and 1000–1100 cm−1 were assigned to the vibrational modes
of tetrahedral phosphate ions (PO43−) in HA. The absorption bands characteristic of the
liberation and stretching vibration of the hydroxyl group in HA were located at 631, 3567,
3642 cm−1. The LiO2Li bond was seen at 810 cm−1. The absorption band split into two
bands at 1462 and 1411 cm−1 corresponded to the carbonate (CO32−) species originating
from atmospheric CO2. The mentioned bonds are the main characteristics for the formation
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of type-B carbonated apatite, in which CO32- substitutes PO43−. The bands at 1646, 2980,
and 3431 cm−1 were for the adsorbed water molecules [8,19,32,33].
Table 2. The calculated values of average crystallite size (D) and relative density (ρ) of HA and
Li-doped HA samples.
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Figure 2. FTIR spectrum of: (a) HA. (b) HA-0.5Li. (c) HA-1Li. (d) HA-2Li. (e) HA-4Li sintered at
1250 ◦C.
The FE-SEM micrographs in Figure 3 show the surface morphology of the synthesized
powders by ball-milling before sintering at 1250 ◦C. It can be observed that the Li dopant
had no considerable effect on the morphology and size of the HA nanoparticles. There are
spherical agglomerates on the surface of larger particles possessing various size distribu-
tions. Figure 4 sh ws the FE-SEM micrographs of the fracture surfaces of sampl s after
sintering. The Li-doped samples had heterogeneous microstructures, except for HA-1Li
sample. The HA-2Li and HA-4Li samples showed nonuniform grain growth. Particle sizes
were between 60 and 120 nm.
2.2. Bioactivity Behavior
Apatite Growth Ability
Figure 5 shows the SEM micrographs of all samples and EDS for HA and HA-1Li after
soaking in SBF for 7 days. The formation of the cauliflower-like apatite layer on the surface,
characteristic of bioactivity, was evident. According to Figure 5, the formation of an apatite
layer decreased slightly by increasing the Li content from 1.0 to 2.0 and 4.0 wt.%, although
the layers were thicker than those of HA and HA-0.5Li samples.
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.3. iological Behavior
2.3.1. Cellular Behavior
To study the growth characteristic of the MG63 osteoblast-like cells (MG63-cells),
optical microscopy images were captured from the interface of samples and the culture
media. As observed in Figure 6, the HA-0.5Li and HA-1Li samples, compared to the
HA sample, indicated suitable cell proliferation. It is known that cell growth on the
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surface is a significant feature for the investigation of biocompatibility, which influences
cell differentiation in the later stages [31]. The highest cell proliferation took place in the
HA-1Li sample, but decreased significantly in the HA-2Li and HA-4Li samples.
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Figure 7 il ustrates the optical density of the G63-cel s se ded on samples examined
by MT as ay for 3, 5, and 7 days. Cells cultured on ev ry sample increas d with ncreasing
culture ime. Figure 7 shows that HA-0.5Li and HA-1Li samples had the ig est optical
density of cell growth. T e cell viabil ty of Li-doped samples compared with that of the
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HA sample at different periods showed that adding 0.5 and 1.0% Li did not lead to any
cytotoxic results. Additionally, the optical density, as a criterion for cellular behavior (or
cell proliferation), was significantly lower (p < 0.05) for the HA-2Li and HA-4Li samples.
A p-value less than 0.05 (p < 0.05) was considered to have statistical significance. The
differences were shown by brackets and asterisks in histograms (* for p < 0.05; ** for p < 0.01;
*** for p < 0.001 and **** for p < 0.0001).
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Figure 8 shows the increase in the alkaline phosphatase (ALP) activity by Li ions, an
important marker in bone growth and differentiation. It was confirmed in this study that
lower and higher Li compared to its optimal amount (HA-1Li) showed less favorable ALP
activity and, therefore, less osteogenesis [18]. Previous studies have shown that in animal
models, Li has increased osteogenesis [34]. The results of most studies have shown that
the optimal concentration of Li can increase the osteogenesis effects, including osteogenic
differentiation, proliferation, and cell protection [35,36]. Li probably affects a wide range
of cellular signaling along with the proteins involved, although its exact mechanism of
action and concentration dependence are not clear yet [37]. So far, much evidence has been
obtained regarding the effect of Li on the Wnt/β-catenin and PI3K-AKT pathways [38–40].
2.3.2. Antibacterial Behavior
Figure 9 shows the results of antibacterial tests against the two E. coli and S. aureus
bacteria. Li doping enhanced the antibacterial properties of HA nanoparticles. Moreover,
the E. coli bacterium had lower resistance than S. aureus.
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The crystalli e structure of HA could be stabilized or destabilized due to the ionic radius
of the substituted dopant. The reason for adding any dopants into the HA structure is to
improve morphology and densification [41,42]. Based on XRD characterization (Figure 1)
and Tables 1 and 2, HA allows the substitution of dopant in its structure, and thus, its
lattice parameters changed. The HA-2Li and HA-4Li samples showed less lattice volume
variations. This can be attributed to the formation of Ca10Li(PO4)7 phase, and consequently,
the placement of Li+ in the HA structure [8,43]. To explain this, it is important to know
where the Li ions were placed in the HA structure. The sites depicted in Figure 10 are the
locations that can be filled by the dopant ions in the HA structure. Depending on the ionic
radius, a dopant can replace Ca2 or Ca1 sites. The cations with a radius larger than the
Ca ion would fill Ca2 and the smaller cations in Ca1 sites. As mentioned before, Li+ has a
smaller ionic radius than Ca2+; therefore, it was substituted in the Ca1 places or inserted
as an extra atom in the HA structure (interstitial atom) [44,45]. Considering Table 2, due
to the formation of another phase (Li-calcium-phosphate) at higher concentrations of Li+,
the crystallinity of HA decreased because there were not as many Li ions to substitute the
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Ca ions [7,8]. According to Table 2, the size of HA crystals can be explained as follows.
First, the addition of Li (0.5 and 1.0 wt.%) resulted in a more compact structure and smaller
crystal size. Second, at the higher Li contents (2.0 and 4.0 wt.%), Li-calcium-phosphate
phase formation consumed some of the Li+, resulting in lower Li+ available for doping
in the HA structure. This resulted in lower densification of the HA lattice causing an
increase in the HA crystal size [8,43,46]. Moreover, as shown in Figure 3, the grain growth
of HA-2Li and HA-4Li samples before sintering was due to the formation of a liquid
phase containing Li and Ca phosphates [47]. After sintering (Figure 4), the densification
was increased in HA-0.5Li and HA-1Li samples because Li+ is small and caused higher
diffusion. Considering a study by Lee et al., the higher Li doping provoked more grain
growth by diminishing the grain boundary energy [48,49].
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Bioactivity is described as the material feature allowing a strong, adherent, and direct
bonding with the bone in a living body [18]. Based on the data reported in Figure 5,
the formed apatite with an atomic ratio of Ca/P = 1.55 covered some of the HA surface.
However, HA-1Li formed a higher amount of apatite. The Ca/P atomic ratio of the apatite
deposits in HA-1Li was 1.67, which was the same as the Ca/P atomic ratio of HA in the
bone structure. The presence of Ca10Li(PO4)7 and Ca3(PO4) phases generated in HA-1Li
can be attribut d to the higher amount of apatite formed in HA-1Li compared to HA.
Negative charges were formed on the HA surface to form apatite while immersed in SBF
due to phosphate and hydroxyl groups. The negative charges interacted with Ca2+, and
afterward, the surface acquired positive charges [50]. Due to the displacement of positive
charge ions such as Ca2+ and Li+ released from the surfaces of Li-doped samples with
H3O+ ions, the formation of hydroxyl ions could be stimulated. The hydroxyl ions combine
with the positive charge ions in the SBF and form apatite deposits [43]. Furthermore,
cellular behavior was investigated by representing the density of proliferated cells as in
Figure 6. The numbers of attached cells onto HA-0.5Li and HA-1Li samples confirmed
that their surface features were suitable for cellular growth [8,51]. The observations in
Figures 6 and 7 can be explained as follows. Low-level doping (HA-0.5Li and HA-1Li)
resulted in a change in the surface topography and subsequently increased the HA density
and cell proliferation [13,43]. However, high-level doping (HA-2Li and HA-4Li) increased
solubility and increased release of Li+, causing some of the effects of cellular toxicity
in MG63-cells (Figure 7), which led to less proliferation and viability cell. The results
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showed that HA-1Li was the optimal sample that provided the best biocompatibility and
proliferation of cells [43,52–54].
The schematic in Figure 11 further illustrates the interaction of Li ions with cells.
Wnt/beta-catenin is a vital signaling pathway in bone tissue recovery that stimulates
proliferation and osteoblastic differentiation [55,56]. Wnt signaling also increases bone
differentiation by inhibiting the expression of the PPARλ adipose-specific gene [57]. Studies
have shown that activating the Wnt signaling pathway in adipose-derived mesenchymal
stem cells prevents them from differentiating into fat and leads to their differentiation into
osteoblast cells [58,59]. Beta-catenin, which plays an essential role in the transcription of
genes involved in proliferation and differentiation [60] via a destruction complex, is led
by a destruction complex to ubiquitination and finally to proteasomal degradation [61].
This destruction complex is composed of the proteins Axin, protein phosphate 2A (PP2A),
adenomatous polyposis coli (APC), glycogen synthase kinase 3 (GSK-3), and casein kinase
1a (CK1a) [62,63]. This destruction complex also causes phosphorylation of beta-catenin,
whose degradation by proteasome prevents its accumulation in the cytoplasm [64]. The
canonical Wnt signaling pathway activity decomposes the destruction complex and dis-
rupts its function [65]. To activate the Wnt signaling pathway, the Wnt glycoproteins bind
to the frizzled receptor and LRP5/6 coreceptors, which phosphorylate the Dishevelled
protein [66]. Activated Dishevelled protein inhibits GSK-3B, which prevents the phospho-
rylation of beta-catenin. As a result, beta-catenin is isolated from APC and accumulates
in the cytoplasm [67]. Studies have shown that Li increases accumulated beta-catenin in
the cytoplasm by activating Wnt and inhibiting GSK-3B [18,68]. Accumulated beta-catenin
eventually enters the nucleus where it binds to transcription factors (TCF-LEFs) for tran-
scription of target genes dependent on the Wnt pathway [69,70]. Studies on MG63-cells
have shown that Li ions increase the ALP, OCN, OPN, Col1α1, Runx2, LRP5, and LRP6 pro-
teins. Li also increases mineral nodules and calcium deposition [71–73]. However, there are
numerous and sometimes contradictory reports about the dual effect of the Wnt pathway
on the differentiation of stem cells into bone cells, so that the activation of this pathway
first has an increasing role (up to the 14th day) and then a decreasing role on osteogenic
differentiation. Li also reduces osteoclastogenesis by affecting the PI3K-AKT pathway [74].
PI3K-AKT is an essential signaling pathway for growth, proliferation, and survival [75]. Li
enhances the entire activity of AKT by increasing AKT phosphorylation. Activated AKT
inhibits GSK-3β, which subsequently downregulates NFATc1 expression [76,77], and this
reduces osteoclast differentiation [78]. In general, it seems that Li, by affecting cellular
signaling pathways, causes increasing osteoblast differentiation, proliferation, and cell
protection, but decreasing osteoclast differentiation.
According to the antibacterial results against E. coli and S. aureus in Figure 9, the
bacterial viability decreased by increasing Li ion dopant in the HA structure. Because
gram-negative bacteria (E. coli) have a thinner peptidoglycan layer than gram-positive
bacteria (S. aureus), the entry of Li+ into E. coli and structural damage were less limited [35].
In other words, the purines in the outer layer of gram-negative bacteria acted as a channel
for the entry of low molecular weight substances; consequently, the amount of damage to E.
coli was higher at similar Li contents [79–81]. The results of electron microscopy in previous
research have shown that bacteria lose their natural shape upon exposure to the metal,
related to metal accumulation on the bacterial cell wall [82]. The schematic displayed in
Figure 12 shows possible Li function in the face of bacteria. In general, Li destroys the
cell wall, leading to leakage of cytoplasmic contents and dehydration [83]. Moreover, the
entry of Li ions into bacteria can damage polynucleotide chains such as RNA and DNA. Li
disrupts the function of enzymes by altering the conformation of proteins [83,84].
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4.1. Material Preparation
The HA po r fr a natural source, namely a cow’s cortical bone.
In a furnace with an air environment, the cortical b ne of a cow was burned with an
oxyac tylene flame and calcined at 800 ◦C for 2 h [85]. The other chemicals used in the
experiments were all from Merck, Darmstadt, Germany: Li carbonate (Li2CO3) and ste r c
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containing measured amounts of micro powder HA, Li carbonate, and 2 wt.% stearic
acid were prepared. According to previous studies, stearic acid was used as the process
control agent (PCA) to prevent agglomeration of the powder [27]. The HA and HA with Li
carbonate were milled using a high-energy planetary ball mill (Fritsch Pulverisette, Ider
Oberstein, Germany, inert tungsten carbide cups and balls) with a ball to powder ratio
of 10:1, under argon gas for 20 h at 300 rpm. One cup contained HA powder, while the
other included HA and Li carbonate particles. To prepare samples from each group of
synthesized powder, 0.6 g was pressed at 150 MPa to form tablets 15 mm in diameter.
Afterward, the tablets were sintered for 2 h at 1250 ◦C.
4.2. Characterization
The phase composition, crystallite size, unit cell volume, lattice strain, and crystallinity
percentage of samples were determined by X-ray diffraction (PANalytical Company, Nether-
lands) using CuKα (λ = 1.542 Å). The lattice constants (a, b, and c) of samples were
measured by standard HCP unit-cell plane spacing relationship using Equation (1) [86]:
1/d2 = (4(h2 + hk + k2))/(3 a2) + (l2/c2) (1)
where d is lattice spacing and h, k, and l are Miller indices of the diffractions. The calculated
values are listed in Table 1. The unit cell volume (V) was determined by Equation (2):
V = 0.866·a2c (2)
The average crystal size (D) was calculated using the Scherrer equation, Equation (3):
D = 0.94 λ/(β cos(θ)) (3)
in which λ is the wavelength of CuKα radiation (λ = 1.542 Å), θ is Bragg diffraction angle,
and β is full width at half maximum (FWHM) as in Equation (4):
β2 = β2exp − β2standard (4)
where βexp and βstandard are the measured and the instrumental widths, respectively [87].
The crystallinity percentage (%Xc) was estimated using Equation (5) [88]:
%Xc = (k/β002)3 (5)
where k is a constant (=0.24), and β002 is the FWHM of the (002) plane. The density (ρ) was
measured using the Archimedes method as in Equation (6) [51]:
Density(g/cm3) = (wt.(air)/(wt.(air) − wt.(water))ρ(water)) (6)
The wt.(water) and wt.(air) are weights of the samples in water and air, respectively.
ρ(water) is the density of water. The theoretical density of all samples was considered as
3.156 g/cm3. Fourier transfer infrared spectroscopy (FTIR, Perkin-Elmer Spectrum 400,
Waltham, MA, USA) was used for determining the functional group of the samples over the
wavenumber range of 400–4000 cm−1. Field-emission scanning electron microscopy (FE-
SEM, Tescan, Brno, Czech Republic) with an accelerating voltage of 15 kV was employed
to analyze the microstructure and morphology of samples.
4.3. Bioactivity Behavior
Apatite Growth Ability
To evaluate apatite growth ability, samples were immersed in 20 mL SBF prepared
according to the extensively used recipe by Kokubo [89]. The ionic concentrations in SBF
were almost like human blood plasma. The specimens were stored in an incubator for
7 days at 37 ◦C. During the incubation period, the SBF was refreshed every day. After
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the 7th day, they were washed in deionized water (DI) and dried at room temperature.
Afterward, the samples were analyzed by scanning electron microscopy (SEM, Tescan,
Brno, Czech Republic) and EDS to observe the formation and growth of bioactive apatite.
4.4. Biological Behavior
4.4.1. Cellular Behavior
MG63-cells were used to evaluate the effects of HA and Li-doped HA samples in
culture medium on cell proliferation. Before immersing in the culture media, all samples
were autoclaved for 15 min at 121 ◦C. MG63-cells were seeded in a 24-well plate (Falcon,
Franklin Lakes, NJ, USA) with a density of 2 × 105 cells/well, containing Dulbecco’s
modified eagle media (DMEM) with 10% fetal bovine serum and 1% Pen-Strep antibi-
otic. Optical microscopy (model-1X832-Deck Inverted Microscope, Olympus, Hamburg,
Germany) monitored the cell developments in culture sets. Afterward, the plates were
stored in a humidified incubator (n-biotek NB-203XL) for 7 days at 37 ± 1 ◦C and 5% CO2.
The cell aggregation in the interface of culture media/specimens was watched at the end
of day 7. The cellular behavior of all samples was examined by colorimetric MTT assay
(3-(4,5 dimethylthiazol-2-yl)-2, 5-diphenyl tetrazolium bromide) (Sigma Inc., Marlborough,
MA, United States) using MG63-cells in the third, fifth, and seventh day of culture. After
incubation, the culture medium was exchanged with 100 µL of conditioned culture medium
containing 10% MTT solution and kept for 4 h. Then, the culture medium was eliminated,
and 100 µL of dimethyl sulfoxide (DMSO) was added to dissolve the formazan crystals. An
ELISA microplate reader (Sunrise-Tecan, Austria) calculated the optical absorbance of the
resulting blue-violet solution at a wavelength of 570 nm. All samples were also exposed to
MG63-cells for 7 and 14 days to assess the ALP activity. After incubation, the MG63-cells
were washed with PBS, lysed by lysis buffer, incubated for 30 min at 37 ◦C and held for
12 h at 4 ◦C. Afterward, the cells were settled into a tube and centrifuged at 12,000 rpm for
10 min. Then, the supernatant and p-nitrophenyl phosphate solution (1 to 20) were mixed
and incubated for 1 h at 25 ◦C. The ALP activity was determined utilizing the fluorescence
microscope system (Cytation 5, BioTek, Winooski, VT, USA) at a wavelength of 405 nm.
4.4.2. Antibacterial Behavior
On HA and Li-doped HA samples, the antibacterial characteristics against E. coli and
S. aureus were performed based on direct interaction of nanoparticles with bacteria by
the colony-forming unit (CFU) test [90]. For this purpose, the nanoparticles produced by
the ball milling process were first washed with ethanol and DI water, and then dried. A
suspension of nanoparticles with a concentration of 100 µg/mL in DI water was prepared,
and 106 CFU/mL of bacteria were added to it, followed by incubation for 6 h at 150 rpm
shaking speed. A suspension containing only bacteria was considered as the control sample.
Eventually, 100 µL suspension of each sample was spread onto LB plates and allowed to
grow for 12 h at 37 ◦C. Finally, colonies were counted and compared with those on the
control sample to determine the CFU reduction percentage.
The ALP, MTT, and antibacterial results were expressed as the mean of three indepen-
dent experiments and plotted as mean ± standard deviation (SD). One-way analysis of
variance (ANOVA) was performed using Minitab 17 software. Student’s t-test was used
for comparison between experimental groups and control groups. A p-value less than 0.05
(p < 0.05) was considered to have statistical significance. The differences were shown by
brackets and asterisks in histograms (* for p < 0.05; ** for p < 0.01; *** for p < 0.001 and
**** for p < 0.0001).
5. Conclusions
A ball milling technique followed by sintering at 1250 ◦C was applied to prepare
HA and Li-doped HA samples. The samples were characterized by XRD, FE-SEM and
FTIR. The results indicated that the crystallinity achieved was over 95% and the crystallites
were in the range of 59–89 nm. The 1.0 wt.% Li-doped sample proved the optimal sample
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because it showed the smallest crystallite size and the highest crystallinity (over 98%). In
addition, in vitro bioactivity tests conducted in SBF, MTT, and the ALP assay demonstrated
the highest bioactivity and cell proliferation for the optimal sample. Results of the antibac-
terial assay also showed that Li doping enhanced the antibacterial properties of HA. The
antibacterial effect on gram-negative E. coli was more than on the gram-positive S. aureus.
Consequently, the 1.0 wt.% Li-doped HA might be a favorable material for bone scaffold
application due to its optimal biological properties.
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